| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.089 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |